RecruitingNCT06572306

Pharmacist-led Continuous Glucose Monitoring

Investigating the Impact of Pharmacist-led Flash Continuous Glucose Monitoring on Clinical and Behavioral Health Outcomes


Sponsor

University of South Florida

Enrollment

40 participants

Start Date

Sep 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: 1. to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring blood glucose with a glucometer). 2. to assess change in continuous glucose monitoring-derived glycemic outcomes among the pharmacist-led continuous glucose monitoring cohort (intervention group) 3. to assess change in health behavior among the pharmacist-led continuous glucose monitoring cohort (intervention group)


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether having a pharmacist guide you through using a continuous glucose monitor (CGM) — a small sensor worn on the skin that tracks blood sugar levels — can help people with type 2 diabetes improve their blood sugar control. **You may be eligible if...** - You have type 2 diabetes - Your most recent HbA1c (3-month blood sugar average) is 8% or higher, meaning your sugar control needs improvement - You own a compatible smartphone that works with the FreeStyle Libre 2 CGM system - You currently use a glucometer to check your blood sugar **You may NOT be eligible if...** - You have used a continuous glucose monitor in the past 6 months - You are pregnant or planning to become pregnant - You have had severe low blood sugar requiring help from someone else - You are on dialysis or use systemic steroids - You have an allergy to medical adhesives Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFreeStyle Libre 2/Libre 3+ Continuous Glucose Monitor

Subjects included in the intervention group (continuous glucose monitoring) will be recruited from the USF Health Department of Family Medicine. Each subject will be enrolled for 12 weeks.


Locations(1)

USF Health Department of Family Medicine

Tampa, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06572306


Related Trials